NeoGenomics, Inc. NEO
Set alert
16.49 USD -0.89 -5.12%
At close
16.59 +0.10 +0.61%
Pre-market · Nov 3, 7:29 AM ET
16.29 Day range 17.66
7.07 52-week range 20.15
- YTD
- +40.22%
- 1 year
- +68.61%
- Open
- 17.66
- Prev close
- 17.38
- Mkt cap
- 2.13B
- Vol
- 1.71M
- Avg vol
- 2.01M
- EPS
- -0.24
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.29
- High
- 17.66
- Forward P/E
- 52.42
- Beta
- 1.83
- Short ratio
- 5.78
- Inst. own
- 115.09%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 16, 2027
- 50-d avg
- 17.68
- 200-d avg
- 12.78
- 1y target
- 23.78
Analyst view
Consensus: buy
Buy
Price target (mean) 23.78 +44.2% upside
Now 16.49
- Target (low)
- 19.00
- Target (mean)
- 23.78
- Target (high)
- 35.00
Ratings (0m) 11 8 buy · 3 hold · 0 sell
- Strong buy2
- Buy6
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 12
- 2 months ago 12
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.06455 | 0.05 – 0.08 | 0.06 | +7.6% | 210.55M | +10.7% | 11 |
| Next quarter | 0.054 | 0.01 – 0.09 | 0.01 | +440.0% | 206.42M | +10.6% | 10 |
| Current year | 0.204 | 0.18 – 0.22 | 0.12 | +70.0% | 808.14M | +11.1% | 10 |
| Next year | 0.31455 | 0.22 – 0.39 | 0.204 | +54.2% | 886.88M | +9.7% | 11 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 29, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 29, 2026 | BTIG | Reiterated | Buy | Buy |
| Oct 6, 2026 | StoneX | Maintained | Buy | Buy |
| Oct 6, 2026 | Needham | Maintained | Buy | Buy |
| Oct 6, 2026 | BTIG | Upgrade | Neutral | Buy |
| Jul 29, 2026 | Needham | Maintained | Buy | Buy |
| Jul 24, 2026 | Benchmark | Maintained | Buy | Buy |
| Apr 29, 2026 | Benchmark | Upgrade | Hold | Buy |
| Apr 29, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 29, 2026 | Leerink Partners | Upgrade | Market Perform | Outperform |
| Feb 24, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 17, 2026 | Needham | Maintained | Buy | Buy |
| Jan 12, 2026 | Needham | Reiterated | Buy | Buy |
| Sep 12, 2025 | TD Cowen | Maintained | Buy | Buy |
| Sep 2, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 29, 2025 | Needham | Maintained | Buy | Buy |
| Aug 4, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Jul 30, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 29, 2025 | William Blair | Downgrade | Outperform | Market Perform |
| Jul 29, 2025 | Needham | Maintained | Buy | Buy |
| May 6, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| May 1, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Apr 30, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Apr 30, 2025 | Leerink Partners | Downgrade | Outperform | Market Perform |
| Apr 29, 2025 | Needham | Maintained | Buy | Buy |
| Apr 17, 2025 | Goldman Sachs | Maintained | Buy | Buy |
| Feb 26, 2025 | Piper Sandler | Maintained | Overweight | Overweight |
| Feb 19, 2025 | B of A Securities | Maintained | Neutral | Neutral |
| Feb 19, 2025 | Needham | Maintained | Buy | Buy |
| Jan 28, 2025 | Goldman Sachs | Maintained | Buy | Buy |